Literature DB >> 14597364

Lip cancer treatment with high dose rate brachytherapy.

José-Luis Guinot1, Leoncio Arribas, María Luisa Chust, José Luis Mengual, Enrique García Miragall, María Carrascosa, Pedro Pablo Escolar, Vicente Crispín, Carmen Guardino.   

Abstract

We present 39 patients with lip carcinoma treated with HDR, (needles) with 5-5.5 Gy per 8-10 fractions b.i.d. (total dose 40.5-45 Gy). Three-year cause-specific survival and local control are 91 and 88% (95% T1-2, 74% T4, p<0.05). Acute and chronic reactions are like LDR cases. We think that HDR results are equivalent to LDR.

Entities:  

Mesh：

Year:  2003        PMID： 14597364     DOI： 10.1016/s0167-8140(03)00271-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  11 in total

1.  [Brachytherapy for the treatment of head and neck cancer].

Authors:  J E Meyer; C Brocks; S Maune; V Strnad; J A Werner; B Wollenberg; G Kovács
Journal:  HNO       Date:  2010-09       Impact factor: 1.284

2.  High-dose-rate brachytherapy using molds for lip and oral cavity tumors.

Authors:  Teruhisa Unetsubo; Hidenobu Matsuzaki; Mitsuhiro Takemoto; Kuniaki Katsui; Marina Hara; Norihisa Katayama; Takahiro Waki; Susumu Kanazawa; Jun-Ichi Asaumi
Journal:  Radiat Oncol       Date:  2015-04-08       Impact factor: 3.481

3.  Dosimetric analysis and clinical outcomes in CT-based mould brachytherapy in early oral cancers in patients unfit for surgery.

Authors:  Ashutosh Mukherji; Sinnatamby Mourougan; Kandasamy Saravannan; Singhavajala Vivekanandam; K Sathyanarayana Reddy
Journal:  J Contemp Brachytherapy       Date:  2015-04-01

4.  Long term results of PDR brachytherapy for lip cancer.

Authors:  Bengt Johansson; Leif Karlsson; Lennart Hardell; Jan Persliden
Journal:  J Contemp Brachytherapy       Date:  2011-07-06

5.  HDR and LDR Brachytherapy in the Treatment of Lip Cancer: the Experience of the Catalan Institute of Oncology.

Authors:  Arrate Querejeta Ayerra; Estefanía Palacios Mena; Joan Pera Fabregas; Cristina Gutiérrez Miguelez; Ferran Guedea
Journal:  J Contemp Brachytherapy       Date:  2010-04-01

6.  Evaluation of patients with oral squamous cell carcinoma treated by radical irradiation with mold radiotherapy using a customized device: a retrospective clinical study.

Authors:  Tadahide Noguchi; Yasushi Sugiura; Akihiro Dohi; Manabu Yamada; Naruo Okada; Ken-Ichi Sasaguri; Satoru Takahashi; Yoshiyuki Mori
Journal:  J Med Case Rep       Date:  2022-04-29

7.  ORIFICE (Interventional Radiotherapy for Face Aesthetic Preservation) Study: Results of Interdisciplinary Assessment of Interstitial Interventional Radiotherapy (Brachytherapy) for Periorificial Face Cancer.

Authors:  Luca Tagliaferri; Ilaria Giarrizzo; Bruno Fionda; Mario Rigante; Monica Maria Pagliara; Calogero Casà; Claudio Parrilla; Valentina Lancellotta; Elisa Placidi; Alessandra Salvati; Gabriella Macchia; Stefano Gentileschi; Maria Antonietta Blasi; Alessio Giuseppe Morganti; Francesco Bussu; Ketty Peris; Gaetano Paludetti; Vincenzo Valentini
Journal:  J Pers Med       Date:  2022-06-24

Review 8.  High dose rate brachytherapy for oral cancer.

Authors:  Hideya Yamazaki; Ken Yoshida; Yasuo Yoshioka; Kimishige Shimizutani; Souhei Furukawa; Masahiko Koizumi; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2012-11-23       Impact factor: 2.724

9.  Pulsed dose rate brachytherapy of lip cancer.

Authors:  Krystyna Serkies; Adam Ziemlewski; Tomasz Sawicki; Joanna Kamińska; Rafał Dziadziuszko
Journal:  J Contemp Brachytherapy       Date:  2013-09-20

10.  High dose rate interstitial brachytherapy for early stage lip cancer using customized dental spacer.

Authors:  Koji Masui; Hideya Yamazaki; Gen Suzuki; Daisuke Shimizu; Kanako Kawabata; Naoki Noguchi; Tadashi Takenaka; Ken Yoshida; Naoya Murakami; Masayuki Naito; Toshiro Yamamoto; Narisato Kanamura; Satoshi Komori; Akifumi Oshita; Jun Asai; Kei Yamada
Journal:  J Radiat Res       Date:  2020-05-22       Impact factor: 2.724
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.